Evidence map›Paper›PMID 34915089›Full record

ArticleJournal of virological methods2022

Improvement of SARS-COV-2 screening using pooled sampling testing in limited RT-qPCR resources.

Mostefa Bensaada, Mohamed Amine Smaali, Oussama Bahi, Khalid Bouhedjar, Foudil Khelifa, Feriel Sellam, Saad Mebrek

Abstract read
In one paragraph

Article in Journal of virological methods, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mostefa BensaadaLaboratory of cardiovascular, genetic and nutritional diseases, Farhat Abbes University, Sétif, Algeria.
Mohamed Amine SmaaliMolecular biology Laboratory, National Center of Biotechnology Research, Constantine, Algeria.
Oussama BahiLaboratory of Mathematical Medialization and Simulation MMS University of Tamanrasset Algeria, Algeria.
Khalid BouhedjarBioinformatics Laboratory, National Center of Biotechnology Research, Constantine, Algeria.
Foudil KhelifaPasteur Institute of Algeria, Constantine, Algeria.
Feriel SellamGenetic diagnosis and microscopy laboratory, Health and biotechnology division, National Research Center of Biotechnology, Constantine, Algeria. Electronic address: f.sellam@crbt.dz.
Saad MebrekBiochimistry and immunology Laboratory, Health and biotechnology division, National Center of Biotechnology Research, Constantine, Algeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19 is a worldwide pandemic representing the most challenging global health crisis currently. Screening tests availability are a problematic task due to resource-limited abilities of some countries using RT-qPCR technique for SARS-COV-2 detection.

objectiveTo cope with these health emergencies, in particular with this COVID-19 pandemic, states with low molecular diagnostic resources must optimize their capacity in molecular tests. We aimed to design a simple and effective strategy to improve inputs in the RT-qPCR tests as we attempted to check the financial advisability of using such an approach by calculating reduction rate of the test unit cost.

methodsThe used RNA was taken from suspected Covid-19 positive people. Nasopharyngeal swabs were collected at Pasteur Institute Diagnostic Center, Constantine, Algeria, 2020. We have optimized a screening strategy by grouping 16 individuals per pool, without reducing the sensitivity of RT-qPCR.

resultsA 1/16 dilution of a positive sample was a practical limit that does not require the use of robotic systems or mathematical modeling to construct the pools. The financial analysis of our strategy has shown that the costs can be reduced to 90 %. The pooled testing strategy that was proven in this study could be recommended to help COVID-19 containment in countries with low potential screening infrastructures using RT-qPCR technique by reducing the number of tests required to identify all positive subjects.

Indexed as

COVID-19SARS-CoV-2COVID-19 TestingHumansPandemicsReal-Time Polymerase Chain ReactionSensitivity and SpecificitycoronavirusCOVID-19PandemicPooling samples testingRTqPCRSARS−COV-2

Identifiers

PMID34915089
PMCPMC8667353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.